We need your mantras for a new project! Share with us.
We are aware of and actively working on an issue where the first page/opening posts of threads with more than one page are not able to be accessed. We hope to have this resolved soon. Thank you for your patience!
Enhertu Improves Survival in People With HER2-Low MBC
moderators
Posts: 10,272
A New Standard of Care? Enhertu Improves Survival in People With Metastatic HER2-Low Breast Cancer
June 6, 2022
Compared with doctors' choice of chemotherapy, Enhertu (chemical name: fam-trastuzumab-deruxtecan-nxki) improved both progression-free survival and overall survival in people diagnosed with previously treated metastatic HER2-low breast cancer. Read more...
0
Categories
Join Us on Zoom: Upcoming virtual support groups. Read more...
Share more about you! Fill out your profile.